Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteraemia of urinary tract origin relate to sex and hospital- vs. community-acquired origin

International Journal of Medical Microbiology

Volumn 302, Issue 3, 2012, Pages 129-134

  Skjøt Rasmussen, Line ^a   Ejrnæs, Karen ^b   Lundgren, Bettina ^c   Hammerum, Anette M ^a   Frimodt Møller, Niels ^d  

^a STATENS SERUM INSTITUT   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Bacteraemia; Bacterial pathogenesis; Escherichia coli; Extraintestinal virulence; UTI

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; CEFPODOXIME; CEFTIOFUR; CHLORAMPHENICOL; CIPROFLOXACIN; ESCHERICHIA COLI PROTEIN; GENTAMICIN; HLYD PROTEIN; NALIDIXIC ACID; PAPAH PROTEIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; VIRULENCE ASSOCIATED PROTEIN; VIRULENCE FACTOR;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; COMMUNITY; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; ESCHERICHIA COLI; FEMALE; HISTOPATHOLOGY; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; PHYLOGENY; RISK FACTOR; SEXUAL TRANSMISSION; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; SEX FACTORS; SURVIVAL ANALYSIS; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 84862337547     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2012.03.002     Document Type: Article

References (35)

1. Aarestrup F.M., Wiuff C., Mølbak K., Threlfall J.E. Is it time to change fluoroquinolone breakpoints for Salmonella spp.?. Antimicrob. Agents Chemother. 2003, 47:827-829.
2. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 2000, 66:4555-4558.
3. CLSI Performance Standards for Antimicrobial Susceptibility Testing, 18th Informational Supplement, M100-S18 2008, Clinical and Laboratory Standards Institute, Wayne, PA.
4. Cooke N.M., Smith S.G., Kelleher M., Rogers T.R. Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates. J. Clin. Microbiol. 2010, 48:1099-1104.
5. DANMAP, 2010. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. ISSN 1600-2032. (accessed 08.12.11). http://www.danmap.org/pdfFiles/Danmap_2010.pdf.
6. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15:167-193.
7. Ejrnæs K., Stegger M., Reisner A., Ferry S., Monsen T., Holm S.E., Lundgren B., Frimodt-Møller N. Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation. Virulence 2011, 2:528-537.
8. Gordon D.M., Clermont O., Tolley H., Denamur E. Assigning Escherichia coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR triplex method. Environ. Microbiol. 2008, 10:2484-2496.
9. Hekker T.A.M., Groeneveld A.B.J., Simoons-Smit A.M., de Man P., Connell H., MacLaren D.M. Role of bacterial virulence factors and host factors in the outcome of Escherichia coli bacteraemia. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19:312-316.
10. Jaureguy F., Carbonnelle E., Bonacorsi S., Clec'h C., Casassus P., Bingen E., Picard B., Nassif X., Lortholary O. Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin. Microbiol. Infect. 2007, 13:854-862.
11. Johnson J.R., Delavari P., O'Bryan T.T. Escherichia coli O18:K1:H7 isolates from patients with acute cystitis and neonatal meningitis exhibit common phylogenetic origins and virulence factor profiles. J. Infect. Dis. 2001, 183:425-434.
12. Johnson J.R., Kuskowski M.A., Gajewski A., Soto S., Horcajada J.P., Jimenez de Anta M.T., Vila J. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J. Infect. Dis. 2005, 191:46-50.
13. Johnson J.R., Kuskowski M.A., O'Bryan T.T., Maslow J.N. Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia. J. Infect. Dis. 2002, 185:1439-1447.
14. Johnson J.R., Russo T.A. Extraintestinal pathogenic Escherichia coli: "The other bad E. coli" J. Lab. Clin. Med. 2002, 139:155-162.
15. Johnson J.R., Russo T.A., Scheutz F., Brown J.J., Zhang L., Palin K., Rode C., Bloch C., Marrs C.F., Foxman B. Discovery of disseminated J96-like strains of uropathogenic Escherichia coli O4:H5 containing genes for both PapG(J96) (class I) and PrsG(J96) (class III) Gal(alpha1-4)Gal-binding adhesins. J. Infect. Dis. 1997, 175:983-988.
16. Johnson J.R., Russo T.A., Tarr P.I., Carlino U., Bilge S.S., Vary J.C., Stell A.L. Molecular epidemiological and phylogenetic associations of two novel putative virulence genes, iha and iroN (E. coli), among Escherichia coli isolates from patients with urosepsis. Infect. Immun. 2000, 68:3040-3047.
17. Johnson J.R., Scheutz F., Ulleryd P., Kuskowski M.A., O'Bryan T.T., Sandberg T. Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J. Clin. Microbiol. 2005, 43:3895-3900.
18. Johnson J.R., Stell A.L. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 2000, 181:261-272.
19. Johnson J.R., Stell A.L., Kaster N., Fasching C., O'Bryan T.T. Novel molecular variants of allele I of the Escherichia coli P fimbrial adhesin gene papG. Infect. Immun. 2001, 69:2318-2327.
20. Laupland K.B., Gregson D.B., Church D.L., Ross T., Pitout J.D. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin. Microbiol. Infect. 2008, 14:1041-1047.
21. Lefort A., Panhard X., Clermont O., Woerther P.-L., Branger C., Mentré F., Fantin B., Wolff M., Denamur E. Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. J. Clin. Microbiol. 2011, 49:777-783.
22. Maslow J.N., Mulligan M.E., Adams K.S., Justis J.C., Arbeit R.D. Bacterial adhesins and host factors: role in the development and outcome of Escherichia coli bacteremia. Clin. Infect. Dis. 1993, 17:89-97.
23. Moreno E., Andreu A., Pigrau C., Kuskowski M.A., Johnson J.R., Prats G. Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J. Clin. Microbiol. 2008, 46:2529-2534.
24. Moreno E., Planells I., Prats G., Planes A.M., Moreno G., Andreu A. Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia versus strains causing pyelonephritis and other sources of bacteremia. Diagn. Microbiol. Infect. Dis. 2005, 53:93-99.
25. Olesen B., Kolmos H.J., Orskov F., Orskov I. A comparative study of nosocomial and community-acquired strains of Escherichia coli causing bacteraemia in a Danish University Hospital. J. Hosp. Infect. 1995, 31:295-304.
26. Olesen B., Kolmos H.J., Orskov F., Orskov I., Gottschau A. Bacteraemia due to Escherichia coli in a Danish university hospital, 1986-1990. Scand. J. Infect. Dis. 1995, 27:253-257.
27. Restieri C., Garriss G., Locas M.C., Dozois C.M. Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains. Appl. Environ. Microbiol. 2007, 73:1553-1562.
28. Rijavec M., Müller-Premru M., Zakotnik B., Zgur-Bertok D. Virulence factors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin. J. Med. Microbiol. 2008, 57:1329-1334.
29. Ron E.Z. Distribution and evolution of virulence factors in septicemic Escherichia coli. Int. J. Med. Microbiol. 2010, 300:367-370.
30. Ruiz J., Simon K., Horcajada J.P., Velasco M., Barranco M., Roig G., Moreno-Martinez A., Martinez J.A., Jiménez de Anta T., Mensa J., Vila J. Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J. Clin. Microbiol. 2002, 40:4445-4449.
31. Russo T.A., Johnson J.R. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 2000, 181:1753-1754.
32. Russo T.A., Johnson J.R. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003, 5:449-456.
33. Sannes M.R., Kuskowski M.A., Owens K., Gajewski A., Johnson J.R. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J. Infect. Dis. 2004, 190:2121-2128.
34. Tseng C.-C., Wu J.-J., Liu H.-L., Sung J.-M., Huang J.-J. Roles of host and bacterial virulence factors in the development of upper urinary tract infection caused by Escherichia coli. Am. J. Kidney Dis. 2002, 39:744-752.
35. Wang M.-C., Tseng C.-C., Chen C.-Y., Wu J.-J., Huang J.-J. The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection. Clin. Infect. Dis. 2002, 35:1161-1166.